backgrounda
multidrugresist
mdr
pathogen
continu
emerg
substanti
amount
pressur
identifi
new
drug
candid
carboxyl
polyeth
also
refer
polyeth
antibiot
uniqu
class
compound
outstand
potenc
varieti
critic
infecti
diseas
target
includ
protozoa
bacteria
virus
characterist
molecul
key
interest
select
high
potenc
sever
mdr
etiolog
agent
objectivealthough
mani
studi
publish
carboxyl
polyeth
antibiot
recent
review
class
drug
purpos
review
provid
reader
overview
spectrum
activ
polyeth
antibiot
mechan
action
toxic
potenti
drug
candid
combat
drugresist
infecti
diseas
conclusionpolyeth
ionophor
show
high
degre
promis
potenti
control
drugresist
bacteri
parasit
infect
despit
long
histori
use
class
drug
limit
medicin
chemistri
drug
optim
studi
report
thu
leav
door
open
opportun
futur
scifind
pubm
main
search
engin
use
locat
articl
relev
topic
present
present
review
keyword
use
search
specif
name
compound
present
review
well
gener
term
polyeth
ionophor
carboxyl
polyeth
polyeth
antibiot
polyeth
antibiot
carboxyl
ionophor
repres
uniqu
class
compound
report
potent
antibiot
belong
larger
famili
natur
occur
ionophor
first
use
term
ionophor
refer
molecul
abil
bind
metal
ion
facilit
transport
across
cellular
membran
chemophysiolog
properti
made
polyeth
ionophor
use
tool
studi
cation
transport
mechan
ration
biolog
activ
polyeth
antibiot
believ
affect
target
cell
mean
modif
permeabl
cellular
membran
cation
metal
speci
polyeth
ionophor
possess
distinct
structur
featur
crucial
abil
interact
metal
speci
featur
includ
exterior
alkyl
backbon
confer
lipophil
characterist
oxygenrich
intern
caviti
bind
metal
ion
natur
occur
ionophor
group
three
categori
regard
mechan
membran
permeabl
alter
first
group
mobil
carrier
bind
metal
speci
intern
polar
caviti
thu
shield
charg
second
group
quasiionophor
molecul
form
transmembran
hydrophil
channel
metal
ion
flow
membran
last
group
consist
neutral
ionophor
facilit
diffus
cation
across
membran
accord
membran
potenti
natur
occur
carboxyl
ionophor
rel
high
molecular
weight
amu
lipidsolubl
compound
display
high
affin
cation
k
na
ca
thu
yield
mobil
cation
complex
freeli
travel
across
biolog
membran
affin
specif
metal
ion
differ
electrostat
neutral
cation
posit
charg
carboxyl
abil
form
ionic
quasiion
bond
cation
except
lasalocid
natur
occur
carboxyl
ionophor
possess
affin
na
k
lasalocid
form
dimer
dival
complex
ca
mg
metal
complex
format
result
paracycl
complex
result
headtotail
hydrogen
bond
normal
physiolog
steadi
state
live
cell
depend
establish
intracellular
extracellular
concentr
gradient
na
k
intracellular
concentr
k
higher
na
extracellular
concentr
respect
revers
ion
concentr
gradient
essenti
cell
function
carboxyl
ionophor
easili
penetr
cellular
membran
owe
lipophil
properti
perturb
intracellular
cation
balanc
owe
intrins
necess
establish
transmembran
electr
potenti
cell
metabol
mean
establish
ion
gradient
carboxyl
ionophor
present
signific
biolog
interest
therapeut
util
also
possibl
use
chemophysiolog
dynam
combin
tradit
current
therapeut
biolog
activ
molecul
produc
sever
microorgan
low
cost
predict
manner
thu
industri
product
well
establish
via
industri
ferment
repres
asset
replac
augment
exist
therapi
owe
establish
resist
polyeth
antibiot
show
broad
spectrum
bioactiv
includ
antibacteri
antifung
antiparasit
antivir
tumor
cell
cytotox
addit
previous
mention
biolog
activ
sever
studi
investig
potenti
herbicid
antiinflammatori
activ
highli
activ
molecul
well
effect
cn
immunoregulatori
system
tabl
antibacteri
potenti
carboxyl
ionophor
wide
document
report
discoveri
compound
typic
mention
activ
gramposit
gramneg
bacteria
well
fungi
report
easili
gather
carboxyl
polyeth
molecul
outstand
potenc
numer
pathogen
bacteria
drugsensit
drugresist
fact
potenc
seriou
threat
methicillinresist
staphylococcu
aureu
mrsa
vancomycinresist
enterococci
vre
rival
clinic
use
drug
vancomycin
oxacillin
add
potenti
util
point
difficult
fulli
assess
true
valu
molecul
potenti
therapeut
agent
simpli
basi
report
gather
none
molecul
assay
anim
model
infect
bacteria
thu
stage
summar
report
present
later
carboxyl
polyeth
select
potent
antibacteri
agent
vitro
appeal
antibacteri
agent
abil
inhibit
growth
mrsa
vre
low
concentr
major
public
health
threat
pattern
emerg
report
antibacteri
potenti
carboxyl
polyeth
respect
strong
select
toward
gramposit
bacteria
monensin
narasin
salinomycin
nigericin
lenoremycin
septamycin
carriomycin
noboritomycin
alborixin
ionomycin
lysocellin
lasalocid
evalu
eight
gramposit
bacteria
cocci
rod
filament
well
seven
gramneg
bacteria
four
fungal
speci
ionomycin
show
potent
activ
gramposit
bacteria
mic
vari
rang
contrast
one
compound
display
activ
test
gramneg
bacteria
mic
sever
carboxyl
ionophor
report
similar
biolog
activ
profil
gramneg
gramposit
bacteria
grisorixin
lonomycin
octacyclomycin
dianemycin
lonomycin
b
c
antibiot
inostamycin
inostamycin
b
leuseramycin
gener
fungi
resist
carboxyl
ionophor
sever
report
mic
valu
greater
highest
test
concentr
except
sever
speci
fungi
paecilomyc
variotii
candida
albican
saccharomyc
cerevisia
penicillium
digitatum
report
moder
sensit
carboxyl
polyeth
exampl
grisorixin
monensin
narasin
salinomycin
lenoremycin
carriomycin
alborixin
dianemycin
lysocellin
leuseramycin
mic
valu
vari
rang
p
variotii
c
albican
cerevisia
p
digitatum
quit
sensit
sever
carboxyl
polyeth
lysocellin
lenoremycin
nigericin
mic
valu
compound
recent
studi
antifung
capac
carboxyl
ionophor
focus
opportunist
infect
pneumocysti
carinii
hiv
patient
develop
aid
particular
need
new
effect
prophylact
therapi
pneumocytosi
lasalocid
nigericin
figur
two
common
carboxyl
ionophor
shown
signific
inhibitori
effect
growth
p
carinii
vitro
lasalocid
induc
reduct
cyst
trophozoit
concentr
respect
nigericin
concentr
effect
reduc
morpholog
fungi
although
cytolyt
effect
cell
monolay
observ
lasalocid
test
vivo
show
promis
activ
prophylact
use
includ
abil
prevent
occurr
pneumon
corticosteroidimmunosuppress
spraguedawley
rat
dosedepend
manner
dosag
lasalocid
mgkgday
protect
infect
rat
wherea
dose
mgkgday
report
safe
nontox
rat
group
protect
diseas
emerg
spread
resist
strain
malari
parasit
sever
antimalari
drug
market
present
specif
chloroquin
constitut
seriou
public
health
threat
countri
around
world
poor
address
emerg
resist
strain
simultan
use
one
drug
known
differ
mechan
action
moa
consid
import
chang
approach
fight
malaria
approach
slow
develop
resist
individu
drug
thu
limit
spread
resist
strain
success
combin
therapi
depend
avail
molecul
uniqu
moa
recent
year
great
deal
effort
dedic
discoveri
new
antimalari
agent
among
potenti
candid
report
thu
far
carboxyl
ionophor
report
gather
emerg
molecul
stand
potenti
antimalari
drug
candid
sever
reason
first
carboxyl
ionophor
report
potent
vitro
antimalari
agent
ic
valu
nanomolar
picomolar
rang
carboxyl
ionophor
typic
organ
three
subclass
first
categori
includ
compound
specif
monoval
cation
alborixin
lonomycin
nigericin
grisorixin
narasin
salinomycin
cationomycin
monensin
figur
second
includ
molecul
specif
dival
cation
calcimycin
figur
third
includ
molecul
show
less
specif
toward
monoval
dival
cation
lycocellin
lasalocid
ionomycin
three
subgroup
carboxyl
ionophor
specif
mono
valent
cation
report
potent
apart
cationomycin
ic
ic
valu
rang
alborixin
ic
lonomycin
ic
nigericin
ic
grisorixin
ic
narasin
ic
salinomycin
ic
second
carboxyl
ionophor
also
report
potent
activ
vivo
gumilla
et
al
evalu
vivo
antimalari
potenti
alborixin
lonomycin
nigericin
narasin
monensin
use
rat
infect
plasmodium
chabaudi
plasmodium
vinckei
petteri
alborixin
lonomycin
nigericin
narasin
monensin
show
signific
vivo
antimalari
activ
decreas
parasitemia
day
p
chabaudi
p
vinckei
petteri
infect
mice
overal
ed
vari
mgkg
carboxyl
ionophor
specif
monoval
ion
includ
alborixin
lonomycin
nigericin
narasin
monensin
seem
potent
three
subclass
vivo
case
vitro
therapeut
index
use
intraperiton
rout
administr
lonomycin
nigericin
narasin
monensin
lasalocid
rang
adoveland
schrevel
also
assess
vivo
antimalari
activ
monensin
nigericin
use
p
vinck
petteri
infect
mice
ed
ed
valu
monensin
mgkg
respect
ed
ed
nigericin
mgkg
respect
monensin
seem
effect
cure
mice
nigericin
mice
receiv
mgkg
monensin
cure
wherea
onethird
mice
receiv
dose
nigericin
cure
third
sever
studi
report
compound
could
act
select
manner
level
toxic
vari
one
subclass
carboxyl
ionophor
anoth
gumila
et
al
report
vitro
differenti
ionophor
activ
plasmodium
falciparum
normal
mammalian
cell
human
jurkat
lymphoblast
macrophag
cell
line
seem
mammalian
cell
affect
compound
nigericin
alborixin
lonomycin
narasin
monensin
concentr
significantli
least
higher
ic
malari
parasit
wherea
ic
narasin
monensin
nigericin
malari
parasit
vari
rang
mv
macrophag
vari
lv
ld
jurkat
lymphoblast
author
also
report
vivo
toxic
seem
depend
subclass
molecul
specif
toward
monoval
dival
cation
speci
gumilla
et
al
assess
acut
subacut
toxic
alborixin
lonomycin
nigericin
narasin
monensin
use
rat
infect
p
chabaudi
p
vinckei
petteri
alborixin
display
highest
acut
toxic
ld
mgkg
intraperiton
administr
overal
carboxyl
ionophor
specif
monovalent
complex
alborixin
lonomycin
nigericin
narasin
monensin
seem
toxic
ld
valu
mgkg
ld
valu
polyeth
specif
dival
metal
ion
hand
vari
rang
mgkg
similar
find
berger
et
al
found
acut
toxic
lasalocid
nigericin
mgkg
respect
fourth
two
carboxyl
ionophor
report
significantli
potent
chloroquin
adoveland
schrevel
assess
antimalari
activ
monensin
nigericin
alongsid
chloroquin
show
vitro
respect
potent
fifth
sever
carboxyl
ionophor
report
outstand
activ
chloroquineresist
strain
otoguro
et
al
publish
two
report
effect
sever
carboxyl
ionophor
evalu
chloroquineresist
sensit
strain
p
falciparum
alongsid
sever
drug
market
present
antimalari
agent
artesum
artemisin
chloroquin
pyrimethamanin
amodiaquin
quinin
trimethamin
trimethoprim
studi
reveal
carboxyl
ionophor
lonomycin
nigericin
narasin
salinomycin
dianemycin
monensin
lysocellin
extrem
potent
chloroquineresist
strain
p
falciparum
ic
valu
vari
rang
nm
molecul
seem
potent
standard
drug
mention
earlier
ic
valu
drug
vari
valu
nm
artemeth
ic
potent
compound
cytotox
mammalian
cell
human
diploid
embryon
cell
also
assess
studi
sever
ionophor
lasalocid
octocyclomycin
display
high
select
index
highest
select
index
chloroquineresist
strain
chloroquinesensit
strain
compound
show
higher
potenc
select
toward
chloroquineresist
strain
compar
chloroquinesensit
strain
last
author
perform
compar
assess
vivo
effect
artesun
artemeth
plasmodium
berghei
infect
mice
show
narrow
therapeut
window
ed
mgkg
lowest
evalu
found
toxic
mgkg
berger
et
al
estim
acut
toxic
mgkg
author
report
anoth
compound
activ
vitro
chloroquineresist
strain
p
falciparum
ic
nm
show
activ
similar
artemeth
artesun
potent
artemisinin
chloroquin
pyrimethamin
moder
select
index
vivo
activ
oral
chloroquineresist
strain
ed
mgkg
close
artemeth
chloroquin
artesun
far
acut
toxic
concern
ld
mgkg
report
final
carboxyl
ionophor
affect
malaria
parasit
mean
mechan
distinct
drug
avail
present
although
conjectur
subject
author
believ
moa
could
similar
chloroquin
other
believ
complet
differ
gener
accept
carboxyl
ionophor
act
via
antitransport
cation
h
insert
cellular
membran
adoveland
schrevel
believ
could
result
alkalin
food
vacuol
parasit
similar
manner
chloroquin
chloroquin
report
act
two
way
increas
intern
ph
food
vacuol
bind
ferriprotoporphyrin
thu
prevent
crystal
hemozoin
accumul
toxic
level
insid
vacuol
mechan
propos
gumilla
et
al
differ
chloroquin
accord
author
antitransport
cation
h
justifi
outstand
potenc
compound
simpl
reason
chang
occur
plasma
membran
infect
erythrocyt
reduc
effici
ion
shuttl
across
membran
author
believ
carboxyl
ionophor
mere
insert
plasma
membran
complet
intern
insid
cell
close
proxim
parasit
inhibit
develop
either
alter
ion
content
disturb
preestablish
ionic
gradient
host
parasit
cytosol
parasit
reportedli
sensit
shizont
stage
extrem
close
structur
set
carboxyl
ionophor
report
potent
antimalari
monensin
nigericin
lonomycin
grisorixin
molecul
share
uniqu
interconnect
furan
pyran
ring
key
differ
hawaiimycini
establish
weak
antimalari
activ
ic
ngml
p
falciparum
absenc
termin
carboxyl
group
crystal
structur
type
compound
reveal
termin
carboxyl
moieti
either
implic
ion
coordin
involv
hydrogen
bond
distant
oh
group
toxic
concern
remain
primari
hindranc
develop
carboxyl
polyeth
antimalari
drug
apart
issu
gather
literatur
carboxyl
polyeth
possess
great
potenti
antimalari
drug
candid
lead
optim
carboxyl
polyeth
owe
outstand
potenc
vitro
vivo
uniqu
moa
studi
publish
gumilla
et
al
illustr
possibl
semisynthet
modif
molecul
gener
desir
drug
candid
author
report
therapeut
index
could
improv
case
monensin
lasalocid
therapeut
index
monensin
po
synthet
analogu
monensin
methyl
ether
ip
therapeut
index
lasalocid
ip
analogu
lasalocid
ip
sp
apicomplexan
protozoan
parasit
etiolog
agent
coccidiosi
diseas
affect
cattl
poultri
attempt
control
diseas
anticoccidi
drug
gener
ad
feed
anim
sever
carboxyl
polyeth
among
drug
approv
use
control
therapeut
coccidiosi
first
approv
applic
veterinari
carboxyl
ionophor
prophylact
therapeut
treatment
coccidiosi
poultri
carboxyl
ionophor
report
also
posit
impact
growth
anim
maduramicin
salinomycin
narasin
lasalocid
monensin
preval
feed
addit
market
present
sever
carboxyl
ionophor
also
report
anticoccidi
util
chicken
turkey
although
common
addit
use
sever
carboxyl
ionophor
report
effect
addit
market
present
dirlam
et
al
perform
compar
studi
anticoccidi
activ
salinomycin
maduramicin
chicken
infect
sever
pathogen
strain
eimeria
eimeria
tenella
eimeria
necatrix
eimeria
acervulina
eimeria
maxima
eimeria
brunett
dose
mgkg
feed
show
broader
spectrum
toler
author
report
anoth
carboxyl
polyeth
outstand
anticoccidi
potenti
agent
dosag
mgkg
cure
chicken
infect
differ
type
eimeria
sp
potent
sever
molecul
salinomycin
narasin
lasalocid
monensin
market
present
report
anticoccidi
effect
e
tenella
chicken
dosag
mgkg
feed
kijimicin
test
along
monensin
salinomycin
chicken
infect
e
tenella
effect
sever
market
drug
anticoccidi
index
aci
versu
monensin
sodium
salt
salinomycin
sodium
salt
endusamycin
show
protect
effect
chicken
infect
e
tenella
e
acervulina
dose
mgkg
feed
toxic
compound
rat
analyz
administ
rat
oral
ld
mgkg
oral
liu
et
al
report
potent
anticoccidi
agent
chicken
infect
e
tenella
dose
mgkg
respect
estim
protect
quantiti
coccidiosi
agent
potent
wellknown
coccidiostat
agent
exampl
monensin
requir
dose
mgkg
lasalocid
requir
dose
mgkg
salinomycin
dose
mgkg
smith
strout
suggest
moa
coccidiocid
effect
carboxyl
ionophor
suggest
anticoccidi
agent
act
either
inhibit
develop
intracellular
parasit
induc
destruct
intracellular
sporoizoid
immunocompet
individu
gener
selflimit
immunocompromis
patient
particularli
aid
patient
infect
sever
becom
increasingli
preval
although
mani
drug
use
clinic
treatment
c
parvum
effect
treatment
infect
aid
patient
limit
screen
sever
anticoccidi
molecul
led
vitro
vivo
examin
sever
carboxyl
ionophor
monensin
maduramicin
salinomycin
alborixin
lasalocid
evalu
respect
activ
c
parvum
compar
control
anticoccidi
agent
monensin
reduc
develop
c
parvum
treatment
maduramicin
alborixin
sever
combin
immun
defici
scid
mice
inocul
oocyst
bovin
oral
gavag
begin
week
post
infect
mgkgday
week
result
reduct
fecal
parasit
load
p
maduramicin
correl
signific
reduct
parasit
load
crosssect
small
intestin
tissu
p
colon
p
alborixin
show
less
effect
result
oocyst
reduct
week
although
toxic
observ
illustr
weight
loss
signific
anticryptosporidi
activ
overwhelm
moder
toxic
parasit
infect
wide
varieti
organ
gondii
best
known
neurolog
effect
particularli
hearti
cystic
stage
gondii
deleteri
activ
induct
toxoplasm
enceph
thu
caus
fatal
cn
lesion
especi
opportunist
pathogen
aid
patient
treatment
toxoplasm
enceph
typic
combin
therapi
pyrimethamin
sulfadiazin
unfortun
type
chemotherapi
effect
cystic
stage
gondii
thu
reactiv
bradyzoit
chronic
especi
cn
previou
data
demonstr
sever
polyeth
antibiot
highli
activ
tachyzoit
stage
gondii
doubl
vitro
vivo
studi
bradyzoit
stage
reveal
immunofluores
electron
microscopi
low
dosag
monensin
significantli
alter
cytolog
physiolog
swollen
cyst
larg
number
vacuol
gondii
tempor
vivo
mous
brain
gondii
bradyzoit
evalu
exposur
yield
signific
antiparasit
activ
sixhour
singl
dose
treatment
monensin
effect
elimin
viabil
lyse
cell
complet
similar
trial
concentr
littl
bradyzoit
swollen
lyse
concentr
parasit
seem
perman
alter
beyond
viabil
electron
microscop
evalu
apart
carboxyl
ionophor
antibiot
two
drug
shown
activ
bradyzoit
stage
atovaquon
ddi
vitro
vivo
test
shown
molecul
take
significantli
longer
time
activ
monensin
monensin
lethal
cystic
form
gondii
rapid
independ
metabol
activ
bradyzoit
coccidian
parasit
n
canium
often
misdiagnos
gondii
owe
recent
discoveri
evalu
antiparasit
therapeut
evalu
although
evalu
predict
result
antimicrobi
effect
natur
occur
carboxyl
polyeth
illustr
examin
inhibit
tachyzoit
multipl
treatment
monoclon
antibodybas
enzym
immunoassay
eia
cell
cultur
flask
ccf
treatment
lesionbas
assay
develop
studi
chemotherapeut
sulfonamid
dihydrofol
reductas
thymidyl
synthas
inhibitor
macrolid
lincosamid
pentamidin
analogu
eight
miscellan
antiprotozo
six
carboxyl
polyeth
evalu
use
treat
neospora
canium
infect
assay
determin
five
six
ionophor
evalu
lasalocid
maduramicin
narasin
monensin
salinomycin
caus
reduct
tachyzoit
induc
lesion
concentr
ccf
assay
lowest
concentr
examin
alborixin
toxic
host
cell
concentr
literatur
review
gather
carboxyl
polyeth
possess
sever
featur
could
qualifi
promis
lead
although
none
report
review
assess
potenc
molecul
alongsid
clinic
use
drug
report
ic
valu
target
howev
signific
molecul
also
report
potenti
inhibit
replic
viru
key
cell
lymphoid
cell
mononuclear
phagocyt
addit
carboxyl
polyeth
proven
effect
acut
well
chronic
infect
vitro
effect
dose
toxic
level
vari
molecul
molecul
molecul
proven
effect
nontox
concentr
group
carboxyl
polyeth
belong
class
antihiv
drug
known
present
carboxyl
polyeth
monensin
kijimicin
evalu
proteas
inhibitor
respect
interfer
posttransl
modif
protein
well
establish
extrem
high
mutat
rate
easili
develop
resist
proteas
inhibitor
alter
activ
site
target
proteas
enzym
whether
carboxyl
polyeth
interfer
posttransl
modif
protein
share
fate
well
establish
time
owe
limit
understand
exact
sequenc
event
compound
monensin
kijimicin
impair
posttransl
modif
none
studi
review
investig
effect
carboxyl
polyeth
anim
model
concentr
inhibit
revers
transcript
activ
viral
replic
ec
vari
rang
ic
concentr
decreas
cell
viabil
ec
cell
primari
infect
determin
highest
test
concentr
ic
remain
compound
vari
rang
tabl
compound
inhibitori
effect
nontox
dose
observ
ratio
ic
ec
vari
rang
tabl
chronic
infect
cell
sensit
higher
cytotox
observ
shown
low
ic
ec
ratio
vari
tabl
believ
carboxyl
ionophor
share
common
moa
hiv
compound
target
differ
stage
hiv
infect
cycl
preand
postabsorpt
step
nakamura
et
al
use
time
addit
design
exposur
cell
molecul
viral
absorpt
partit
agent
two
main
group
basi
moa
first
group
believ
inhibit
viral
absorpt
made
lasalocid
dianemycin
alborixin
second
group
believ
interfer
postvir
adsorpt
event
made
monensin
salinomycin
lasalocid
nigericin
dianemycin
alborixin
kijimicin
yamauchi
et
al
work
specif
kijimicin
test
concentr
confirm
lack
abil
interf
absorpt
step
well
earli
stage
replic
integr
propos
kijimicin
act
decreas
infect
viru
possibl
accomplish
mean
incomplet
glycosyl
dosedepend
studi
effect
monensin
chronic
infect
htlviiib
reveal
mark
inhibitori
effect
proteolyt
process
h
exposur
effect
specif
effect
protein
level
gag
protein
gag
note
effect
express
tat
vif
nef
gene
product
observ
either
monensin
also
show
mark
reduct
format
syncytia
concentr
nm
cell
cocultur
cem
cell
effect
revers
cell
wash
free
monensin
find
later
confirm
second
group
laidlomycin
also
report
induc
dosedepend
inhibit
hiv
replic
moa
laidlomycin
propos
via
inhibit
express
laidlomycin
also
induc
inhibitori
effect
syncithium
format
concentr
low
report
activ
sever
dna
rna
virus
monensin
monensin
b
nigericin
narasin
lasalocid
septamycin
test
transmiss
gasteroenter
coronaviru
newcastl
diseas
viru
ndv
infecti
canin
hepat
viru
infecti
bovin
rhinotrach
viru
agent
show
signific
activ
transmiss
gasteroenter
coronaviru
mic
rang
nigericin
narasin
effect
ndv
mic
rang
septamycin
activ
infecti
canin
hepat
viru
mic
monensin
b
nigericin
narasin
septamycin
effect
infecti
bovin
rhinotrach
viru
mic
rang
resist
chemotherapi
common
clinic
problem
patient
cancer
treatment
tumor
cell
neoplast
cell
often
found
refractori
varieti
drug
differ
structur
mode
action
cancer
refer
mdr
form
multidrug
resist
caus
transmembran
xenobiot
transport
protein
belong
superfamili
atpbind
cassett
abc
transport
efflux
pump
carboxyl
polyeth
interest
antineoplast
drug
candid
sever
reason
show
potent
antiprolif
activ
vitro
vivo
carboxyl
polyeth
nigericin
proven
select
cytotox
inhibit
dna
replic
tumor
cell
vivo
anoth
featur
make
carboxyl
polyeth
even
appeal
antineoplast
drug
candid
abil
revers
multidrug
resist
human
carcinoma
carboxyl
polyeth
report
chemosensit
agent
molecul
select
increas
sensit
cancer
cell
normal
cell
sever
cytotox
agent
clinic
use
anticanc
drug
paclitaxel
kawada
et
al
evalu
effect
sever
carboxyl
ionophor
colchicin
resist
human
carcinoma
mdr
compound
inostamycin
lysocellin
laidlomycin
monensin
dianemycin
leuseramycin
nigericin
lonomycin
c
carriomycin
deoxysalinomycin
antibiot
discov
cancer
cell
respond
better
colchicin
polyeth
ad
simultan
laidlomycin
monensin
dianemycin
leuseramycin
led
potenti
colchicin
cytotox
activ
compound
laidlomycin
potenti
cytotox
cell
compar
tumor
cell
potenti
normal
cell
neglig
ratio
ic
absenc
polyeth
versu
ic
presenc
polyeth
vari
rang
inostamycin
also
report
chemosensit
effect
paclitaxel
cell
small
cell
lung
carcinoma
effect
specif
type
cell
paclitaxel
potenti
note
test
agent
driamycin
vinblastin
methotrex
cisplatin
etoposid
camptothecin
inostamycin
also
report
revers
multidrug
resist
cell
line
use
radiolabel
vinblastin
kawada
et
al
establish
mdr
cell
treat
inostamycin
accumul
drug
inostamycin
act
inhibit
drug
efflux
baibakov
et
al
margoli
et
al
studi
antineoplast
moa
nigericin
establish
nigericin
uniqu
type
cytostat
agent
compound
act
interf
spindl
microtubul
transcriptiontransl
process
directli
rather
alter
intracellular
ph
nigericin
show
antiprolif
potenti
cytostat
agent
ehrlich
ascit
carcinoma
cell
propos
moa
relat
abil
acidifi
intracellular
environ
consequ
h
k
antitransport
abil
believ
decreas
ph
dna
synthesi
halt
near
inhibit
dna
synthesi
achiev
nigericin
ph
incub
medium
addit
studi
util
vivo
method
tridimension
histocultur
human
lung
tissu
normal
cell
present
histocultur
determin
antineoplast
effect
nigericin
select
nigericin
show
effect
either
histolog
normal
cell
dna
synthesi
howev
cancer
tissu
concentr
nigericin
halt
dna
synthesi
case
induc
pyknot
nuclei
dystrop
alter
tumor
expos
nigericin
necrosi
case
anoth
carboxyl
polyeth
ionomycin
also
report
possess
antineoplast
properti
induc
inhibit
growth
human
bladder
cancer
cell
line
vitro
dose
concentr
gradient
time
depend
ionomycin
manner
moa
report
induct
apoptosi
mean
downregul
upregul
bax
ionomycin
also
effect
vivo
inhibit
tumor
growth
sever
carboxyl
polyeth
report
show
ionotrop
chronotrop
hemodynam
properti
critic
role
ca
cardiovascular
contractil
system
predict
least
carboxyl
polyeth
select
ion
lasalocid
well
establish
lasalocid
also
known
posit
ionotrop
agent
canin
studi
lasalocid
abl
increas
contractil
index
heart
approxim
threefold
mgkg
also
report
posit
ionotrop
chronotrop
agent
dog
barbitur
dog
dosag
mgkg
caus
threefold
increas
contractil
well
modest
rise
aortic
pressur
heart
rate
also
induc
drop
total
peripher
resist
follow
drastic
increas
blood
flow
coronari
arteri
left
ventricl
exact
moa
carboxyl
polyeth
induc
contractil
cardiac
muscl
still
unclear
initi
believ
could
result
abil
shuttl
ca
catecholamin
across
membran
refut
discoveri
carboxyl
polyeth
specif
monoval
cation
abl
induc
even
effect
type
respons
nonetheless
believ
catecholamin
partial
involv
effect
molecul
cardiac
muscl
suppress
inhibitor
sever
carboxyl
ionophor
report
possess
cardiovascular
effect
monensin
reportedli
induc
increas
arteri
blood
pressur
myocardi
contractil
total
peripher
resist
intraven
administ
anesthet
cat
dose
mgkg
similar
effect
observ
mgkg
administ
via
rout
anesthet
dog
monensin
also
effect
isol
organ
show
vasoconstrictor
effect
isol
rabbit
aortic
strip
concentr
myocardi
stimul
effect
isol
rabbit
heart
three
carboxyl
ionophor
grisorixin
alborixin
lonomycin
report
similar
effect
grisorixin
induc
coronari
vasodil
effect
dog
dose
associ
mark
increas
coronari
blood
flow
reach
maximum
concentr
dose
gkg
inotrop
hypertens
effect
observ
grisorixin
also
report
cardioton
effect
isol
perfus
rat
heart
guinea
pig
grisorixin
alborixin
mgkgmin
iv
report
increas
blood
pressur
moa
believ
link
intrins
ionophor
potenti
via
abil
molecul
alter
blood
concentr
cation
k
na
moin
et
al
work
anesthet
dog
report
similar
find
mgkg
grisorixin
mgkg
alborixin
increas
ventricular
contractil
forc
systol
diastol
arteri
pressur
associ
increas
plasma
concentr
k
follow
decreas
concentr
na
owe
report
compound
grisorixin
induc
releas
catecholamin
physiolog
respons
associ
releas
catecholamin
also
propos
possibl
justif
cardio
vascular
effect
lonomycin
anoth
carboxyl
polyeth
also
report
induc
coronari
vasodilat
effect
dog
moa
propos
stimul
na
k
atpas
activ
stress
pressman
despit
toxic
carboxyl
polyeth
import
drug
lead
control
variou
cardiovascular
condit
valu
lie
outstand
ionotrop
chronotrop
hemodynam
potenti
molecul
could
prove
lifesav
tool
control
condit
failur
owe
myocardi
infract
similar
form
shock
carboxyl
polyeth
lasalocid
mgkg
proven
effect
restor
dog
cardiogen
shock
similar
data
report
salinomycin
mgkg
accord
pressman
narrow
transport
spectrum
molecul
fewer
undesir
effect
produc
biolog
activ
carboxyl
polyeth
immunoregulatori
herbicid
antiinflammatori
immunoregulatorytwo
measur
usual
adopt
protect
poultri
varieti
diseas
angara
diseas
viru
adv
ndv
promot
growth
includ
vaccin
addit
substanc
antibiot
coccidiostat
vitamin
feed
among
addit
approv
present
sever
carboxyl
polyeth
lasaloicid
monensin
salinomycin
manduramycin
recent
concern
addit
possibl
associ
vaccin
failur
poultri
report
actual
proven
therapeut
agent
cyclophosphamid
corticosteroid
possess
immunomodulatori
properti
munir
et
al
studi
immunomodulatori
effect
salinomycin
monensin
specif
effect
molecul
protect
immun
respons
ndv
adv
vaccin
chicken
author
establish
unlik
cyclophosphamid
salinomycin
dosag
gkg
advers
affect
bursal
splenic
thymic
liver
weight
gain
also
establish
ndv
vaccin
chicken
receiv
salinomycin
mgkg
feed
higher
antibiot
titer
day
compar
unmed
chicken
vaccin
chicken
medic
monensin
mgkg
instead
salinomycin
medic
chicken
also
gain
significantli
weight
p
compar
group
evalu
chicken
challeng
virus
adv
ndv
vaccin
postadv
postndv
challeng
mortal
observ
vaccin
chicken
receiv
salinomycin
clinic
sign
diseas
observ
studi
seem
far
caus
vaccin
failur
carboxyl
polyeth
salinomycin
actual
seem
boost
effect
antindv
antiadv
immun
respons
anoth
carboxyl
polyeth
report
immunoregulatori
potenti
ionomycin
calciumspecif
ionophor
ionomycin
interfer
physiolog
process
increas
intracellular
level
calcium
effect
could
sever
implic
key
cell
immun
system
neutrophil
macrophag
exert
action
product
microbicid
speci
superoxid
anion
via
nadphdepend
process
known
respiratori
burst
respons
situ
trigger
inflammatori
agent
ca
document
enhanc
nadph
oxidas
activ
finkel
et
al
report
ionomycin
concentr
nm
prime
neutrophil
releas
approxim
sevenfold
superoxid
anion
stimul
ionomycin
also
report
induc
cell
activ
herbicidalit
report
biolog
activ
nigericin
also
possess
herbicid
properti
concentrationdepend
studi
effect
nigericin
growth
radicl
garden
cress
seed
show
dosedepend
inhibitori
effect
reduct
elong
achiev
maximum
inhibit
report
nigericin
induc
brown
necrosi
tissu
process
recent
report
topic
antiinflammatori
potenti
sever
anim
model
cutan
inflamm
crotonoil
induct
ear
edema
dianemycin
compar
activ
prednisolon
potent
steroid
antiinflammatori
ed
versu
mgear
antiinflammatori
activ
observ
uvinduc
erythema
test
delay
type
sensit
test
unlik
control
prenisolon
addit
acut
toxic
observ
topic
applic
mgear
acut
toxic
natur
occur
polyeth
ionophor
rel
specif
organ
affect
clear
minim
exposur
activ
compound
initi
type
physiolog
respons
case
higher
organ
specif
mammal
bird
effect
almost
equal
divers
exampl
common
poison
scenario
hors
consum
small
quantiti
feed
prepar
rumin
polyeth
antibiot
die
rather
quickli
wild
turkey
consum
anticoccidi
chicken
feed
die
although
chiral
central
carboxyl
molecul
predict
inonophor
specif
respect
ld
acut
toxic
valu
individu
speci
molecul
equal
divers
unpredict
exampl
ld
se
valu
acut
oral
dose
monensin
mous
mgkg
f
mgkg
rat
mgkg
f
mgkg
dog
mgkg
f
mgkg
rabbit
mgkg
monkey
mgkg
chicken
mgkg
cattl
mgkg
sheep
mgkg
goat
mgkg
swine
hors
mgkg
trout
mgkg
dog
given
daili
oral
dose
mgkg
monensin
year
surviv
evid
toxic
two
lowest
dose
group
four
gener
rat
continu
maintain
diet
contain
ppm
monensin
except
decreas
bodi
weight
gain
compoundrel
effect
reproduct
observ
teratogen
effect
dose
condit
evalu
period
respect
skelet
cardiac
muscl
increas
chronic
lesion
neoplasm
detect
despit
maverick
chemophys
qualiti
ionophor
consider
number
toxicolog
studi
attempt
illustratetransl
specif
toxicolog
pharmacolog
common
polyeth
ionophor
human
health
util
whether
monoval
dival
ionophor
use
molecul
disrupt
ca
concentr
either
form
ca
complex
depolar
membran
potenti
chang
h
concentr
mitochondria
clear
ca
essenti
ion
physiolog
activ
composit
function
entir
human
bodi
daili
function
cardiac
function
especi
sensit
role
ca
owe
intrins
function
ion
role
muscular
contract
expectedli
potent
effect
polyeth
antibiot
observ
mammalian
cardiac
studi
canin
studi
accept
transl
anim
model
human
cardiac
respons
effect
carboxyl
polyeth
ionophor
studi
shown
littl
iv
induc
coronari
dilat
concern
clinic
applic
ionophor
person
coronari
heart
diseas
coronari
arteri
dilat
part
heart
auto
regulatori
respons
occlus
coronari
arteri
vessel
dilat
affect
vessel
presenc
indiscrimin
vasodil
unaffect
vesicl
would
dilat
alreadi
maxim
dilat
obstruct
vessel
would
divert
blood
suppli
away
ischem
region
myocardium
phenomenon
call
coronari
steal
observ
administr
drug
dipyridamol
thrombu
inhibitor
chronic
vasodil
larg
number
popul
affect
coronari
heart
diseas
concern
valid
although
phenomena
experiment
evalu
coronari
steal
observ
recent
vitro
tool
avail
cardiac
toxic
evalu
respect
interact
herg
human
etheragogo
relat
gene
gene
associ
k
v
potassium
ion
channel
repolar
kr
current
cardiac
action
potenti
polyeth
antibiot
yet
critic
evalu
herg
assay
drug
interact
relat
herg
ion
channel
mandat
ich
guidelin
novemb
mandat
consequ
effect
carboxyl
polyeth
ionophor
qt
c
respect
interact
herg
yet
evalu
carboxyl
polyeth
broad
spectrum
antibiot
activ
wide
rang
biolog
target
bacteri
fungal
protozoan
viral
neoplast
cardiovascular
author
also
report
carboxyl
polyeth
immunomodul
agent
vitro
molecul
proven
effect
low
concentr
malaria
parasit
p
falciparum
especi
sensit
sever
compound
ic
valu
nanomolar
rang
base
report
review
argu
carboxyl
polyeth
highli
select
unlik
gram
neg
bacteria
fungi
instanc
gram
posit
bacteria
tend
extrem
sensit
antibiot
moreov
ic
valu
sever
molecul
mammalian
cell
tend
significantli
higher
compar
ic
target
etiolog
agent
despit
interest
featur
current
applic
carboxyl
polyeth
veterinari
medicin
use
control
coccidiosi
feed
absorpt
effici
main
obstacl
use
carboxyl
polyeth
drug
control
human
diseas
seem
issu
toxic
reduct
toxic
carboxyl
polyeth
possess
interest
qualiti
seriou
threat
mrsa
vre
proven
effect
vitro
drug
current
use
clinic
vancomycin
oxacillin
also
shown
effect
sever
resist
bacteri
strain
includ
penicillin
resist
strain
aureu
tetracyclin
resist
strain
micrococcu
sp
aminoglycosid
resist
strain
streptococcu
faecali
macrolid
resist
strain
sarcina
lutea
carboxyl
polyeth
also
proven
effect
namomolar
rang
chloroquin
resist
strain
p
falciparum
potent
resist
strain
sever
current
market
antimalari
drug
mechan
action
malaria
parasit
appear
uniqu
differ
current
util
drug
make
possibl
candid
use
combin
therapi
basi
assess
literatur
polyeth
ionophor
show
high
degre
promis
potenti
control
drugresist
bacteri
parasit
infect
mani
infecti
diseas
fall
umbrella
neglect
diseas
limit
option
therapeut
intervent
furthermor
recent
decad
emphas
import
combin
therapi
longterm
control
diseas
mitig
resist
long
histori
util
polyeth
ionophor
growth
promot
antibiot
agricultur
industri
valid
potenti
costeffect
use
drug
product
applic
polyeth
antibiot
seem
provid
reason
oral
avail
halflif
metabol
gener
stabil
absenc
uv
sensit
chromophor
combin
signific
potenc
despit
long
histori
use
class
limit
medicin
chemistri
drug
optim
studi
report
leav
door
open
opportun
futur
mani
instanc
potenc
vivo
efficaci
control
bacteri
parasit
infect
truli
remark
howev
concern
toxic
need
address
optim
preclin
evalu
basi
avail
literatur
still
insuffici
data
clearli
classifi
molecul
either
toxic
safe
class
sever
carboxyl
polyeth
inde
shown
toxic
anim
model
malaria
result
gener
entir
class
use
vivo
model
cancer
nigericin
recent
report
highli
select
target
cancer
cell
broaden
scope
possibl
util
class
result
organ
care
orchestr
identif
optim
lead
use
vitro
model
follow
vivo
assess
toxic
efficaci
would
seem
yield
viabl
drug
candid
control
drugresist
infecti
diseas
cancer
reason
understand
pharmacokinet
stabil
cost
good
report
toxic
monensin
mgkg
ld
primat
frequent
util
drug
agricultur
make
polyeth
class
attract
group
molecul
optim
develop
human
health
applic
control
drugresist
diseas
malaria
mrsa
scifind
pubm
main
search
engin
use
locat
articl
relev
topic
present
present
review
keyword
use
search
specif
name
compound
present
review
well
gener
term
polyeth
ionophor
carboxyl
polyeth
polyeth
antibiot
antivir
antibacteri
antiproliferativeapoptot
antiinflammatori
